The fund seeks capital appreciation in the long term by investing in small-size companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team focuses on companies experiencing positive dynamic change.
The team believes companies undergoing positive dynamic change offer the best investment opportunities.
Additionally, the team utilizes fundamental analysis to uncover companies experiencing high unit volume growth and positive changes in product cycle and market dynamics.
The team also focuses on traditional growth companies experiencing rapidly growing demand or market dominance.
In addition, the research team emphasizes companies benefitting from new regulations, a new product innovation or new management.
Then the manager constructs a portfolio of stocks from a list of companies favored by the research team and allocates capital based on its conviction level.
Generally, the portfolio holds approximately 50 holdings.
In addition, the fund invests at least 25% of its net assets in technology companies focused in the fields of medicine and information.
Also, the fund invests in cash (and cash equivalents) in times of adverse or unstable market, economic or political conditions.